Biospectrum Jobs

August 19th, 2026 | Wednesday

news4

IQVIA Tops Everest Group’s 2026 Pharma Technology Provider Ranking

IQVIA, a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced that it has been ranked No. 1 in Everest Group’s “Top 50 Pharmaceutical Technology Providers” report for 2026. IQVIA earned the highest overall score among the 50 providers evaluated, receiving 96.8 out of 100. The ranking recognizes IQVIA’s broad technology coverage across the pharmaceutical value chain and its ability to support complex, highly regulated life sciences environments. IQVIA was the only provider in the ranking with technology coverage across all six pharmaceutical value-chain areas assessed: drug discovery and research, clinical development, manufacturing operations, sales and marketing, supply chain and distribution and pharmacovigilance and safety. This breadth of coverage helps customers connect capabilities across the product lifecycle, make better decisions and execute more effectively. IQVIA combines proprietary data and content, deep life sciences expertise, advanced technology and longstanding experience operating in highly regulated, privacy-sensitive environments to help customers address complex challenges with greater confidence. Biopharma customers are looking for more than individual technologies. They demand solutions that work together and a partner that understands the realities of their business.

Read More →

For latest updates follow us on

LinkedIn

This email has been sent to you in association with
www.biospectrumjobs.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2026 MM ACTIV. All rights reserved.

Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.

Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.